Science and Research

Modulate-CF: Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant CFTR in Patients With Cystic Fibrosis Treated With CFTR-modulators

This observational study evaluates the effect of therapy with cystic fibrosis transmembrane regulator (CFTR) modulators on CFTR function measured by the CFTR biomarker intestinal current measurement (ICM), nasal potential difference (NPD) and sweat chloride in a post-approval setting in patients with cystic fibrosis (CF).

Study details
Study-ID: NCT04732910
Study-ID: NCT04732910
DZL Disease Area: CFBE
DZL Disease Area: CFBE
Study Type: Observational
Study Type: Observational
DZL Role: DZL recruiting center, DZL Investigator Initiated Trial, DZL on steering board
DZL Role: DZL recruiting center, DZL Investigator Initiated Trial, DZL on steering board
Funding: DZL, Externally - industry
Funding: DZL, Externally - industry
DZL Participating Sites: BIH / Charité - Associated Partner, BREATH, TLRC, UGMLC
DZL Participating Sites: BIH / Charité - Associated Partner, BREATH, TLRC, UGMLC
Start Date: 01.07.2018
Completion Date: 31.12.2027
Status: Recruiting
Status: Recruiting
DZL recruiting center, DZL Investigator Initiated Trial, DZL on steering board
Link to Study


chevron-down